Phillip Johnson, MD
Family Medicine · Litchfield, ILNPI 1225089683
Payments from drug & device makers
Across 286 payments — averaging $18.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$742
- Lilly USA, LLC$695
- Pfizer$512
- Novo Nordisk$337
- Otsuka America Pharmaceutical, Inc.$226
- Novartis$217
- plus $2K from 38 others
What the payments were for
- Food & beverage$5,04197%
- Education$651%
- Other$671%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$5,172 in reported general payments places this provider in the 90th percentile of 4,116 family medicine providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 499 | $258,169 |
| TrulicityDulaglutide | 168 | $173,089 |
| OzempicSemaglutide | 115 | $136,950 |
| JardianceEmpagliflozin | 217 | $127,239 |
| MounjaroTirzepatide | 86 | $99,445 |
| IngrezzaValbenazine Tosylate | 25 | $91,469 |
| XareltoRivaroxaban | 84 | $62,652 |
| EntrestoSacubitril/Valsartan | 84 | $39,522 |
| MyrbetriqMirabegron | 61 | $30,773 |
| VraylarCariprazine Hcl | 18 | $27,661 |
| JanuviaSitagliptin Phosphate | 42 | $27,530 |
| Tresiba Flextouch U-200Insulin Degludec | 20 | $27,204 |
| Lurasidone Hcl | 40 | $26,996 |
| FarxigaDapagliflozin Propanediol | 41 | $25,249 |
| CaplytaLumateperone Tosylate | 27 | $22,758 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCTrulicity, Mounjaro | $695 | $272,534254 claims |
| PfizerEliquis, Premarin | $512 | $265,926518 claims |
| Novo NordiskOzempic, Fiasp | $337 | $149,209140 claims |
| Boehringer IngelheimJardiance, Tradjenta | $154 | $137,158228 claims |
| Neurocrine Biosciences, Inc.Ingrezza | $190 | $91,46925 claims |
| Johnson & JohnsonXarelto, Risperdal Consta | $74 | $79,62495 claims |
| GSKBreo Ellipta, Incruse Ellipta, Trelegy Ellipta, Arexvy, Arnuity Ellipta | $146 | $68,355164 claims |
| AstraZenecaFarxiga, Symbicort, Breztri Aerosphere | $121 | $42,25593 claims |
| NovartisEntresto | $217 | $39,52284 claims |
| Astellas Pharma US IncMyrbetriq | $29 | $30,77361 claims |
| AbbVieVraylar | $742 | $27,66118 claims |
| MerckJanuvia | $35 | $27,53042 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,116 family medicine providers in Illinois.
Other family medicine in Litchfield
- Daniel BruneCreve Coeur$15M
- Ali BajwaSpringfield$5.8M
- John ElsenEvergreen Park$5M
- Manohar JethaniBerwyn$4.9M
- Tiffany NguyenSkokie$3.9M
- Bradley TorphyChicago$3M
- Diana WidicusRochester$2.6M
- Nicholas WeberEureka$2.5M
- Stanley KochMorton$2.3M
- Mark ChristensenNew Lenox$2.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.